| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Antimicrobial effects of silver nanoparticles | Nanomedicine: Nanotechnology, Biology, and Medicine | 2007 | 4,055 |
| 2 | Biological synthesis of metallic nanoparticles | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 1,870 |
| 3 | Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging | Nanomedicine: Nanotechnology, Biology, and Medicine | 2012 | 1,200 |
| 4 | Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity | Nanomedicine: Nanotechnology, Biology, and Medicine | 2016 | 1,140 |
| 5 | Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 1,137 |
| 6 | Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli | Nanomedicine: Nanotechnology, Biology, and Medicine | 2007 | 1,113 |
| 7 | Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles | Nanomedicine: Nanotechnology, Biology, and Medicine | 2006 | 1,109 |
| 8 | Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis | Nanomedicine: Nanotechnology, Biology, and Medicine | 2011 | 1,106 |
| 9 | Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells | Nanomedicine: Nanotechnology, Biology, and Medicine | 2016 | 1,083 |
| 10 | Mesoporous silica nanoparticles in drug delivery and biomedical applications | Nanomedicine: Nanotechnology, Biology, and Medicine | 2015 | 958 |
| 11 | Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation | Nanomedicine: Nanotechnology, Biology, and Medicine | 2011 | 893 |
| 12 | The big picture on nanomedicine: the state of investigational and approved nanomedicine products | Nanomedicine: Nanotechnology, Biology, and Medicine | 2013 | 865 |
| 13 | The present and future of nanotechnology in human health care | Nanomedicine: Nanotechnology, Biology, and Medicine | 2007 | 730 |
| 14 | Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria | Nanomedicine: Nanotechnology, Biology, and Medicine | 2012 | 714 |
| 15 | Advances in polymeric micelles for drug delivery and tumor targeting | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 709 |
| 16 | Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole | Nanomedicine: Nanotechnology, Biology, and Medicine | 2009 | 637 |
| 17 | Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 607 |
| 18 | Role of nanotechnology in targeted drug delivery and imaging: a concise review | Nanomedicine: Nanotechnology, Biology, and Medicine | 2005 | 605 |
| 19 | Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles | Nanomedicine: Nanotechnology, Biology, and Medicine | 2009 | 604 |
| 20 | Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 554 |
| 21 | Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE | Nanomedicine: Nanotechnology, Biology, and Medicine | 2009 | 544 |
| 22 | Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties | Nanomedicine: Nanotechnology, Biology, and Medicine | 2015 | 517 |
| 23 | Nanostructured lipid carriers: Promising drug delivery systems for future clinics | Nanomedicine: Nanotechnology, Biology, and Medicine | 2016 | 511 |
| 24 | Nanostructure-mediated drug delivery | Nanomedicine: Nanotechnology, Biology, and Medicine | 2005 | 499 |
| 25 | Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations | Nanomedicine: Nanotechnology, Biology, and Medicine | 2018 | 499 |
| 26 | Toxicity issues in the application of carbon nanotubes to biological systems | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 485 |
| 27 | The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold | Nanomedicine: Nanotechnology, Biology, and Medicine | 2008 | 460 |
| 28 | Upconversion nanoparticles: synthesis, surface modification and biological applications | Nanomedicine: Nanotechnology, Biology, and Medicine | 2011 | 445 |
| 29 | Nanotopographical modification: a regulator of cellular function through focal adhesions | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 433 |
| 30 | Milk-derived exosomes for oral delivery of paclitaxel | Nanomedicine: Nanotechnology, Biology, and Medicine | 2017 | 412 |
| 31 | Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 411 |
| 32 | Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue | Nanomedicine: Nanotechnology, Biology, and Medicine | 2015 | 399 |
| 33 | Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent | Nanomedicine: Nanotechnology, Biology, and Medicine | 2015 | 392 |
| 34 | Cell selective response to gold nanoparticles | Nanomedicine: Nanotechnology, Biology, and Medicine | 2007 | 382 |
| 35 | Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications | Nanomedicine: Nanotechnology, Biology, and Medicine | 2011 | 375 |
| 36 | Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform | Nanomedicine: Nanotechnology, Biology, and Medicine | 2013 | 372 |
| 37 | In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 361 |
| 38 | The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes | Nanomedicine: Nanotechnology, Biology, and Medicine | 2013 | 356 |
| 39 | Silver nanoparticles as a safe preservative for use in cosmetics | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 353 |
| 40 | What is nanomedicine? | Nanomedicine: Nanotechnology, Biology, and Medicine | 2005 | 347 |
| 41 | Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues | Nanomedicine: Nanotechnology, Biology, and Medicine | 2008 | 342 |
| 42 | Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases | Nanomedicine: Nanotechnology, Biology, and Medicine | 2015 | 340 |
| 43 | Biological interactions of carbon-based nanomaterials: From coronation to degradation | Nanomedicine: Nanotechnology, Biology, and Medicine | 2016 | 339 |
| 44 | Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2 | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 335 |
| 45 | Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy | Nanomedicine: Nanotechnology, Biology, and Medicine | 2009 | 325 |
| 46 | Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer | Nanomedicine: Nanotechnology, Biology, and Medicine | 2005 | 321 |
| 47 | Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery | Nanomedicine: Nanotechnology, Biology, and Medicine | 2010 | 311 |
| 48 | Effect of ligand density, receptor density, and nanoparticle size on cell targeting | Nanomedicine: Nanotechnology, Biology, and Medicine | 2013 | 310 |
| 49 | PEGylated PLGA nanoparticles for the improved delivery of doxorubicin | Nanomedicine: Nanotechnology, Biology, and Medicine | 2009 | 306 |
| 50 | Toxicity of silica nanoparticles depends on size, dose, and cell type | Nanomedicine: Nanotechnology, Biology, and Medicine | 2015 | 302 |
